Thoughts on combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma

Noa Biran, MD, discusses her thoughts on the promising combination of carfilzomib and daratumumab in revlimid-refractory multiple myeloma patients at the 2018 Annual Meeting. Author: obr Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts